# Joseph C Gathe, Jr, MD, CI – FDA Inspection, Mar 10, 2023

Source: https://www.keypedia.com/records/fda_inspections/joseph-c-gathe-jr-md-ci/ccf6e731-3246-4b8d-8110-ac4e2f9e1817
Source feed: FDA_Inspections

> FDA inspection 1199449 of Joseph C Gathe, Jr, MD, CI, March 10, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199449
- Company Name: Joseph C Gathe, Jr, MD, CI
- Inspection Date: 2023-03-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 806013 - 2012-11-05

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/andrea-a-branche/9ffe9b53-7963-49a6-be4e-25e644f1759f)

Company: https://www.keypedia.com/companies/joseph-c-gathe-jr-md-ci/4ea3d3ec-d339-4ee0-820f-abc8bacffc17

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c